Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP

Detalhes bibliográficos
Autor(a) principal: Funchal, Cláudia da Silva
Data de Publicação: 2005
Outros Autores: Zamoner, Ariane, Quincozes-Santos, André, Loureiro, Samanta Oliveira, Pureur, Regina Pessoa, Wajner, Moacir
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/218302
Resumo: We have previously described that a-ketoisocaproic acid (KIC), the main metabolite accumulating in maple syrup urine disease (MSUD), increased the in vitro phosphorylation of cytoskeletal proteins in cerebral cortex of 17- and 21-day-old rats through NMDA glutamatergic receptors. In the present study we investigated the protein kinases involved in the effects of KIC on the phosphorylating system associated with the cytoskeletal fraction and provided an insight on the mechanisms involved in such effects. Results showed that 1 mM KIC increased the in vitro incorporation of 32P into intermediate filament (IF) proteins in slices of 21-day-old rats at shorter incubation times (5 min) than previously reported. Furthermore, this effect was prevented by 10 lM KN-93 and 10 lM H-89, indicating that KIC treatment increased Ca2+/calmodulin- (PKCaMII) and cAMP- (PKA) dependent protein kinases activities, respectively. Nifedipine (100 lM), a blocker of voltage-dependent calcium channels (VDCC), DL-AP5 (100 lM), a NMDA glutamate receptor antagonist and BAPTA-AM (50 lM), a potent intracellular Ca2+ chelator, were also able to prevent KICinduced increase of in vitro phosphorylation of IF proteins. In addition, KIC treatment was able to significantly increase the intracellular cAMP levels. This data support the view that KIC increased the activity of the second messenger-dependent protein kinases PKCaMII and PKA through intracellular Ca2+ levels. Considering that hyperphosphorylation of cytoskeletal proteins is related to neurodegeneration it is presumed that the Ca2+-dependent hyperphosphorylation of IF proteins caused by KIC may be involved to the neuropathology of MSUD patients.
id UFRGS-2_4a5e42473f623da63351e3d247b3b29b
oai_identifier_str oai:www.lume.ufrgs.br:10183/218302
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Funchal, Cláudia da SilvaZamoner, ArianeQuincozes-Santos, AndréLoureiro, Samanta OliveiraPureur, Regina PessoaWajner, Moacir2021-03-02T04:15:44Z20050364-3190http://hdl.handle.net/10183/218302000527184We have previously described that a-ketoisocaproic acid (KIC), the main metabolite accumulating in maple syrup urine disease (MSUD), increased the in vitro phosphorylation of cytoskeletal proteins in cerebral cortex of 17- and 21-day-old rats through NMDA glutamatergic receptors. In the present study we investigated the protein kinases involved in the effects of KIC on the phosphorylating system associated with the cytoskeletal fraction and provided an insight on the mechanisms involved in such effects. Results showed that 1 mM KIC increased the in vitro incorporation of 32P into intermediate filament (IF) proteins in slices of 21-day-old rats at shorter incubation times (5 min) than previously reported. Furthermore, this effect was prevented by 10 lM KN-93 and 10 lM H-89, indicating that KIC treatment increased Ca2+/calmodulin- (PKCaMII) and cAMP- (PKA) dependent protein kinases activities, respectively. Nifedipine (100 lM), a blocker of voltage-dependent calcium channels (VDCC), DL-AP5 (100 lM), a NMDA glutamate receptor antagonist and BAPTA-AM (50 lM), a potent intracellular Ca2+ chelator, were also able to prevent KICinduced increase of in vitro phosphorylation of IF proteins. In addition, KIC treatment was able to significantly increase the intracellular cAMP levels. This data support the view that KIC increased the activity of the second messenger-dependent protein kinases PKCaMII and PKA through intracellular Ca2+ levels. Considering that hyperphosphorylation of cytoskeletal proteins is related to neurodegeneration it is presumed that the Ca2+-dependent hyperphosphorylation of IF proteins caused by KIC may be involved to the neuropathology of MSUD patients.application/pdfengNeurochemical research. New York, NY. Vol. 30, no. 9 ( 2005), p. 1139-1146Filamentos intermediáriosDoença da urina de xarope de bordoFosforilaçãoα-Ketoisocaproic acidCalciumcAMPIntermediate filamentsMaple syrup urine diseasePhosphorylationAlpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMPEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT000527184.pdf.txt000527184.pdf.txtExtracted Texttext/plain0http://www.lume.ufrgs.br/bitstream/10183/218302/2/000527184.pdf.txtd41d8cd98f00b204e9800998ecf8427eMD52ORIGINAL000527184.pdfTexto completo (inglês)application/pdf3117203http://www.lume.ufrgs.br/bitstream/10183/218302/1/000527184.pdfb247c99acb3db16009fe95dc5d5df32eMD5110183/2183022021-04-12 08:33:24.731533oai:www.lume.ufrgs.br:10183/218302Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-04-12T11:33:24Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
title Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
spellingShingle Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
Funchal, Cláudia da Silva
Filamentos intermediários
Doença da urina de xarope de bordo
Fosforilação
α-Ketoisocaproic acid
Calcium
cAMP
Intermediate filaments
Maple syrup urine disease
Phosphorylation
title_short Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
title_full Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
title_fullStr Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
title_full_unstemmed Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
title_sort Alpha-ketoisocaproic acid increases phosphorylation of intermediate filament proteins from rat cerebral cortex by mechanisms involving Ca²+ an cAMP
author Funchal, Cláudia da Silva
author_facet Funchal, Cláudia da Silva
Zamoner, Ariane
Quincozes-Santos, André
Loureiro, Samanta Oliveira
Pureur, Regina Pessoa
Wajner, Moacir
author_role author
author2 Zamoner, Ariane
Quincozes-Santos, André
Loureiro, Samanta Oliveira
Pureur, Regina Pessoa
Wajner, Moacir
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Funchal, Cláudia da Silva
Zamoner, Ariane
Quincozes-Santos, André
Loureiro, Samanta Oliveira
Pureur, Regina Pessoa
Wajner, Moacir
dc.subject.por.fl_str_mv Filamentos intermediários
Doença da urina de xarope de bordo
Fosforilação
topic Filamentos intermediários
Doença da urina de xarope de bordo
Fosforilação
α-Ketoisocaproic acid
Calcium
cAMP
Intermediate filaments
Maple syrup urine disease
Phosphorylation
dc.subject.eng.fl_str_mv α-Ketoisocaproic acid
Calcium
cAMP
Intermediate filaments
Maple syrup urine disease
Phosphorylation
description We have previously described that a-ketoisocaproic acid (KIC), the main metabolite accumulating in maple syrup urine disease (MSUD), increased the in vitro phosphorylation of cytoskeletal proteins in cerebral cortex of 17- and 21-day-old rats through NMDA glutamatergic receptors. In the present study we investigated the protein kinases involved in the effects of KIC on the phosphorylating system associated with the cytoskeletal fraction and provided an insight on the mechanisms involved in such effects. Results showed that 1 mM KIC increased the in vitro incorporation of 32P into intermediate filament (IF) proteins in slices of 21-day-old rats at shorter incubation times (5 min) than previously reported. Furthermore, this effect was prevented by 10 lM KN-93 and 10 lM H-89, indicating that KIC treatment increased Ca2+/calmodulin- (PKCaMII) and cAMP- (PKA) dependent protein kinases activities, respectively. Nifedipine (100 lM), a blocker of voltage-dependent calcium channels (VDCC), DL-AP5 (100 lM), a NMDA glutamate receptor antagonist and BAPTA-AM (50 lM), a potent intracellular Ca2+ chelator, were also able to prevent KICinduced increase of in vitro phosphorylation of IF proteins. In addition, KIC treatment was able to significantly increase the intracellular cAMP levels. This data support the view that KIC increased the activity of the second messenger-dependent protein kinases PKCaMII and PKA through intracellular Ca2+ levels. Considering that hyperphosphorylation of cytoskeletal proteins is related to neurodegeneration it is presumed that the Ca2+-dependent hyperphosphorylation of IF proteins caused by KIC may be involved to the neuropathology of MSUD patients.
publishDate 2005
dc.date.issued.fl_str_mv 2005
dc.date.accessioned.fl_str_mv 2021-03-02T04:15:44Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/218302
dc.identifier.issn.pt_BR.fl_str_mv 0364-3190
dc.identifier.nrb.pt_BR.fl_str_mv 000527184
identifier_str_mv 0364-3190
000527184
url http://hdl.handle.net/10183/218302
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Neurochemical research. New York, NY. Vol. 30, no. 9 ( 2005), p. 1139-1146
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/218302/2/000527184.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/218302/1/000527184.pdf
bitstream.checksum.fl_str_mv d41d8cd98f00b204e9800998ecf8427e
b247c99acb3db16009fe95dc5d5df32e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801225008931930112